Adeshwar Meditex Limited (BOM:543309)
17.50
+0.70 (4.17%)
At close: Aug 17, 2026
Adeshwar Meditex Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 253 | 245 | 242 | 475 | 242 | 396 | |
Market Cap Growth | -2.78% | 1.07% | -48.94% | 96.42% | -38.98% | - |
Enterprise Value | 312 | 306 | 319 | 620 | 412 | 579 |
Last Close Price | 17.50 | 16.98 | 16.80 | 32.90 | 16.75 | 27.45 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 19.89 | 19.37 | 11.74 | 23.65 | 11.66 | 49.96 |
PS Ratio | 0.45 | 0.44 | 0.29 | 0.60 | 0.29 | 0.61 |
PB Ratio | 0.66 | 0.64 | 0.66 | 1.36 | 0.73 | 1.28 |
P/TBV Ratio | 0.66 | 0.64 | 0.66 | 1.36 | 0.74 | 1.28 |
P/FCF Ratio | 5.17 | 5.01 | 6.64 | 13.93 | 4.19 | - |
P/OCF Ratio | 5.08 | 4.93 | 6.38 | 12.37 | 4.19 | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.56 | 0.55 | 0.38 | 0.78 | 0.50 | 0.89 |
EV/EBITDA Ratio | 10.88 | 10.65 | 6.84 | 11.63 | 7.57 | 16.14 |
EV/EBIT Ratio | 12.79 | 12.51 | 7.66 | 13.11 | 8.39 | 18.07 |
EV/FCF Ratio | 6.39 | 6.25 | 8.73 | 18.19 | 7.15 | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.16 | 0.16 | 0.34 | 0.40 | 0.50 | 0.61 |
Debt / EBITDA Ratio | 2.09 | 2.09 | 2.67 | 2.60 | 3.02 | 5.30 |
Debt / FCF Ratio | 1.23 | 1.23 | 3.41 | 4.07 | 2.85 | - |
Net Debt / Equity Ratio | 0.16 | 0.16 | 0.26 | 0.37 | 0.44 | 0.55 |
Net Debt / EBITDA Ratio | 2.09 | 2.09 | 2.07 | 2.39 | 2.67 | 4.76 |
Net Debt / FCF Ratio | 1.23 | 1.23 | 2.64 | 3.73 | 2.52 | -4.73 |
Asset Turnover | 0.92 | 0.92 | 1.23 | 1.22 | 1.18 | 0.96 |
Inventory Turnover | 2.03 | 2.03 | 2.85 | 2.76 | 2.82 | 2.14 |
Quick Ratio | 2.12 | 2.12 | 1.15 | 0.95 | 0.96 | 0.93 |
Current Ratio | 4.52 | 4.52 | 2.03 | 2.06 | 1.90 | 1.76 |
Return on Equity (ROE) | 3.36% | 3.36% | 5.75% | 5.92% | 6.49% | 3.08% |
Return on Assets (ROA) | 2.49% | 2.49% | 3.82% | 4.51% | 4.40% | 2.97% |
Return on Invested Capital (ROIC) | 3.81% | 3.71% | 6.53% | 7.17% | 7.36% | 4.74% |
Return on Capital Employed (ROCE) | 6.00% | 6.00% | 10.60% | 13.00% | 13.80% | 9.00% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 5.01% | 5.16% | 8.52% | 4.23% | 8.58% | 2.00% |
FCF Yield | 19.35% | 19.94% | 15.06% | 7.18% | 23.86% | -9.11% |
Buyback Yield / Dilution | 0.40% | 0.40% | - | - | - | -37.03% |